Chemotaxis and killing activity of polymorphonuclear leukocytes and CD4+ T-cell count in the 8 HIV-infected patients with continuous viral suppression after HAART
| Patients . | PMN chemotaxis (migrated cells/field) . | PMN killing (%) . | CD4+ count (cells/μL) . | Plasma HIV-RNA copies/mL . |
|---|---|---|---|---|
| Pre-HAART | 22.75 ± 1.4 | 18.75 ± 1.3 | 152 ± 37 | 5.1 log10 |
| Post-HAART | 46.12 ± 2.1* | 36.8 ± 1.2* | 507 ± 96* | ND |
| Patients . | PMN chemotaxis (migrated cells/field) . | PMN killing (%) . | CD4+ count (cells/μL) . | Plasma HIV-RNA copies/mL . |
|---|---|---|---|---|
| Pre-HAART | 22.75 ± 1.4 | 18.75 ± 1.3 | 152 ± 37 | 5.1 log10 |
| Post-HAART | 46.12 ± 2.1* | 36.8 ± 1.2* | 507 ± 96* | ND |
PMN, polymorphonuclear leukocyte; HAART, highly active antiretroviral treatment; ND, not detectable. Data are expressed as mean ± SEM.
P < .05 versus pre-HAART.